BRAIN Biotech AG (ETR:BNN)

BRAIN Biotech AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 22, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	65	48	46	93	96	221
Market Cap Growth	43.00%	2.83%	-50.00%	-3.85%	-56.34%	56.48%
Enterprise Value	60	37	35	89	83	213
Last Close Price	2.96	2.18	2.12	4.24	4.41	10.10
PS Ratio	1.32	0.95	0.84	1.65	1.92	5.63
PB Ratio	-88.83	25.89	3.34	4.03	2.81	5.28
P/TBV Ratio	-	-	-	14.13	7.48	8.74
EV/Sales Ratio	1.21	0.74	0.62	1.58	1.65	5.44
Debt / Equity Ratio	-	11.27	1.89	0.45	0.31	0.27
Net Debt / Equity Ratio	7.07	7.84	-0.07	0.22	0.07	-0.32
Net Debt / EBITDA Ratio	1.44	-3.31	0.16	-2.11	-0.68	3.23
Net Debt / FCF Ratio	0.54	-1.34	0.18	-0.74	-0.30	2.56
Asset Turnover	0.67	0.65	0.70	0.76	0.65	0.52
Inventory Turnover	-	2.41	2.60	2.66	2.72	2.49
Quick Ratio	0.29	0.86	1.41	0.87	0.93	2.78
Current Ratio	1.48	1.42	1.83	1.46	1.42	3.45
Return on Equity (ROE)	-223.66%	-150.49%	-60.16%	-28.34%	-16.67%	-13.77%
Return on Assets (ROA)	-5.92%	-6.25%	-7.06%	-4.67%	-5.12%	-6.16%
Return on Capital Employed (ROCE)	-14.20%	-15.90%	-14.10%	-10.40%	-11.30%	-11.10%
Earnings Yield	-16.43%	-24.65%	-24.02%	-8.94%	-6.84%	-2.25%
FCF Yield	-14.67%	-22.60%	-11.09%	-7.38%	-7.56%	-2.34%
Buyback Yield / Dilution	-	-	-	-	-9.55%	-6.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.